Cellceutix Corp Shares Rise On Two Catalysts

By: via Benzinga
On Monday, Merck & Co. Inc. (NYSE: MRK) announced a definitive agreement to acquire Cubist Pharmaceuticals (NASDAQ: CBST) for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.